The 33rd Annual New Treatments in Chronic Liver Disease 2018 will be held in La Jolla, CA, United States on March 9-11, 2018.
The 33rd Annual New Treatments in Chronic Liver Disease 2018 is a course dedicated to new medications and therapies in the treatment of the following:
Current knowledge of NAFLD and non-alcoholic steatohepatitis and the use of new agents and approaches to treatment of the conditions
The details of the AASLD guidelines for treatment of HCV using DAAs in IFN-free regimens
Therapies for HCV including NS5A, protease and polymerase inhibitors
The algorithm for a therapeutic approach to treatment of HBV using anti-virals
Current options of therapy for hepatocellular carcinoma to determine the best approach for your patients
The skills and management required for transplant hepatology
The diagnosis and treatment of PBC and PSC
Future treatment paradigms for HCV direct-acting antiviral drug
The issues complicating drug treatment in decompensated cirrhosis, hepatic encephalopathy and hyponatremia
Treatment options discussed for patients with ESLD due to alcohol who have complicating factors such as HCV, NASH or inherited genetic disorder
The management of complications beta-blocker therapy in ESLD
The 33rd Annual New Treatments in Chronic Liver Disease 2018 brings together Hepatologists , Physician Assistants , Residents/Fellows , Nurses , Nurse Practitioners , Gastroenterologists , Infectious Disease Specialists and Others desiring an update in these specialty areas .